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Abstract
Ingested glucose powerfully stimulates the secretion of appetite- and metabo-
lism-regulating peptide hormones from the gut – including glucagon-like pep-
tide-1 (GLP-1), neurotensin (NT), and polypeptide YY (PYY). However, the
regional origin of these secretions after glucose stimulation is not well charac-
terized, and it remains uncertain how their secretion is related to glucose
absorption. We isolated and perfused either the upper (USI) or the lower
(LSI) small intestine or the colon from rats and investigated concomitant glu-
cose absorption and secretory profiles of GLP-1, NT, and PYY. In the USI
and LSI luminal glucose (20%, w/v) increased GLP-1 and NT secretion five to
eightfold compared to basal secretion. Compared to the USI, basal and stimu-
lated GLP-1 secretion from the colon was 8–10 times lower and no NT secre-
tion was detected. Luminal glucose stimulated secretion of PYY four to
fivefold from the LSI and from the USI and colon, but the responses in the
USI and colon were 5- to 15-fold lower than in the LSI. Glucose was absorbed
to a comparable extent in the USI and LSI by mechanisms that partly
depended on both SGLT1 and GLUT2 activity, whereas the absorption in the
colon was 80–90% lower. The absorption rates were, however, similar when
adjusted for segmental length. Glucose absorption rates and NT, PYY and in
particular GLP-1 secretion were strongly correlated (P < 0.05). Our results
indicate that the rate of secretion of GLP-1, NT, and PYY in response to glu-
cose, regardless of the involved molecular machinery, is predominantly regu-
lated by the rate of glucose absorption.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
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Introduction
The gut peptide hormones, glucagon-like peptide-1 (GLP-1),
and peptide YY (PYY) play an important role in the regu-
lation of appetite and food intake (Baggio and Drucker
2007; Steinert et al. 2017; Tan et al. 2017), and neu-
rotensin secreted from intestinal N-cells may also inhibit
appetite (Levine et al. 1983). GLP-1, in addition, potenti-
ates glucose-stimulated insulin secretion and thus con-
tributes to the incretin effect (Kreymann et al. 1987).
Over the last two decades, substantial efforts have been
made to uncover the molecular mechanisms underlying
nutrient-stimulated secretion of these peptide hormones
(Gribble and Reimann 2016; Husted et al. 2017), but the
regional anatomical origin of their secretion and its rela-
tion to macronutrient absorption remains unclear. Based
on immunohistochemistry, it appears that in humans NT,
GLP-1 and in particular PYY-positive cells are more
abundant in the distal small intestine and in the colon
(PYY and GLP-1) (Varndell et al. 1985; Evers et al. 1993;
Theodorakis et al. 2006), and mucosal concentrations of
extractable peptides show a similar pattern in mice and
rats (Larsson et al. 1975; Larsson and Rehfeld 1978; Evers
et al. 1993; Svendsen et al. 2015; Wewer Albrechtsen et al.
2016). However, there is no simple relationship between
tissue concentration or number of “specific” enteroen-
docrine cells and actual hormone secretion (Svendsen
et al. 2015; Gribble and Reimann 2016; Kuhre et al.
2016). For instance, the high concentration of these pep-
tides in the colon raises the question whether a similarly
large secretion can be elicited from this part of the gut.
However, the secretion in response to a given nutrient
depends on the expression of the molecular machinery
that is activated by nutrients, and this may vary between
cells from different parts of the intestine. Recent studies
in people with gastric bypass surgery indicate that the
exaggerated increase in GLP-1, NT, and PYY secretion
after oral glucose intake is related to the rate of glucose
absorption rather than the presence of glucose in the gut
(Jørgensen et al. 2012; Jacobsen et al. 2013), and this
assumption is supported by in vitro experiments (Parker
et al. 2012; Kuhre et al. 2014a, 2014b). Nevertheless, this
apparently important relationship has not, to our knowl-
edge, been studied directly in a quantitative manner.
Therefore, the purpose of this study was to examine the
potential relationship between glucose absorption and
glucose-stimulated GLP-1, NT, and PYY secretion from
the different intestinal sections. For this, we used isolated
perfused segments from the rat gut: the upper and lower
half of the small intestine and the colon. In our perfusion
models, all the important physiological parameters such
as cell polarization, contact with normal neighbor cells,
nutrition, and respiration and most importantly for
studies of transmucosal transport: perfusion flow (and
therefore convective drag of absorbed nutrients) are pre-
served (Svendsen and Holst 2016), allowing studies of the
full dynamics of absorption and secretion.
Material and Methods
Ethical considerations
Studies were conducted with permission from the Danish
Animal Experiments Inspectorate (2013-15-2934-00833)
and the local ethical committee and were conducted in
accordance with the EU Directive 2010/63/EU and guide-
lines of Danish legislation governing animal experimenta-
tion (1987) and the NIH (publication number 85–23).
Isolated perfused rat intestine
Male Wistar rats (~250 g) were obtained from Janvier
(Saint Berthevin Cedex, France) and housed two per cage
with ad libitum access to drinking water and chow, fol-
lowing a 12 h light/dark cycle. At the day of experiment,
nonfasted rats were anesthetized with a subcutaneous
injection of Hypnorm/midazolam (0.079 mg fentanyl
citrate + 2.5 mg fluanisone + 1.25 mg midazolam/mL:
0.3 mL/100 g bodyweight). Experiments were conducted
between 09.00 and 10.30 and between 13.00 and 14.00
(equal number of rats at the two times) meaning that the
rats, since they had been exposed to light from 07.00 AM,
had been “semi-fasted” for either 2–3 or 6–7 h prior to
the experiment. This difference in fasting time did not
affect glucose absorption or hormone secretion (data not
shown). Rats were placed on a heated operating table
(37°C), the abdominal cavity was opened, and all parts of
the intestine not to be included for perfusion were
removed after ligation of the supplying vasculature. The
remaining intestine (either the upper or lower half of the
small intestine (USI or LSI) or the colon) was left in situ
in the animal – still connected to its vasculature. The USI
included the segment from the duodenum until approxi-
mately 50 cm from cecum, whereas the LSI included the
lower approximately 50 cm of the small intestine includ-
ing the terminal ileum boarding up to the ileo-cecal valve.
A tube was placed in the lumen and the luminal contents
were emptied by gently flushing with isotonic saline
(room temperature). Thereafter, a steady flow of saline
was applied until the end of experiment (USI and
LSI = 0.5 mL/min, colon = 0.05 mL/min), except for the
stimulation periods were glucose was administered as
described below. The retained intestine was vascularly
perfused (USI and LSI: 7.5 mL/min, colon 3 mL/min) via
a catheter inserted into the upper mesenteric artery (a.
mesenterica sup.) in case of the small intestine or the
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aorta for the colon and perfused with perfusion buffer
using a UP100 Universal Perfusion System from Hugo
Sachs (Harvard Apparatus, March Hugstetten, Germany)
heating the buffer to 37°C. For the colon preparation, the
kidneys were tied off, the spleen, stomach, and small
intestine were removed and the celiac artery (partly per-
fusing the pancreas) were ligated to ensure that only the
colon was perfused. Perfusion buffer was a Krebs-Ringer
bicarbonate buffer supplemented with 0.1%(w/v) BSA
(Fraction V; cat. no. 1.12018.0500, Merck, Ballerup, Den-
mark), 5% (w/v) dextran T70 (to balance osmolarity,
Pharmacosmos, Holbaek, Denmark), 2% (v/v) amino acid
mixture (Vamin, Cat. no. 11,338, Fresenius Kabi, Upp-
sala, Sweden), 3.5 mmol/L glucose, 10 lmol/L 3-isobutyl-
1-methylxanthine (Cat. no.5879, Sigma Aldrich), and
5 mmol/L pyruvate, fumarate and glutamate. The buffer
was oxygenated by gassing with 95% O2/5% CO2 and pH
adjusted to 7.4–7.5. Venous effluent samples were col-
lected each minute from a catheter inserted into the vena
portae, and samples were immediately put on ice. As soon
as perfusion flow was established, the rat was euthanized
by perforation of the diaphragm, and the selected gut seg-
ment was perfused for approximately 30 min before the
experiment was started. For the present experiments, the
stimulant was intraluminal glucose (20% w/v) dissolved
in isotonic saline (room temperature) delivered with an
initial bolus to replace the saline in the intestine (USI and
LSI: 2.5 mL/min for three minutes, colon: 0.25 mL/min
for five minutes) followed by a slower infusion rate for
the remainder of the stimulation period (USI and LSI:
0.5 mL/min, colon: 0.15 mL/min). At the end of the
stimulation period, the lumen was flushed with isotonic
saline (room temperature) at same rates as described
above. In separate experiments the entire small intestine
(103.7  5.4 cm, except ~3 cm of the most proximal
part) was perfused as described above (7.5 mL/min) and
glucose absorption was investigated in response to admin-
istration of 100 mmol/L glucose  10 mmol/L phloridzin
(SGLT1 inhibitor) and 1 mmol/L phloretin (GLUT2 inhi-
bitor). Because of the longer length of the retained intes-
tine, the luminal administrations was in this case given as
an initial bolus of 2.5 mL/min for 5 min followed by
10 min at 0.5 mL/min. Perfusion pressure and effluent
flow rate were closely monitored throughout the experi-
ment and used as an indication of the wellbeing of the
perfused intestinal segment. Both parameters remained
stable during all reported experiments. Therefore, the
measured peptide concentrations in the venous effluent
reflect the actual secretory output (fmol/min = concentra-
tion (fmol/L) 9 flow (L/min)). Length of retained intes-
tine varied little within groups (coefficient of variations:
USI = 10.2%, LSI = 6.89%, colon = 9.41%) but differed
between the USI or LSI and the colon (mean  SEM:
USI = 45.88  2.10 cm, LSI = 48.00  1.65 cm,
colon = 9.81  0.92 cm, PUSI or LSI vs. colon < 0.01) but
not between USI and LSI (P = 0.11). Samples were stored
at 20°C until analysis. The experimental set up has been
described in more detail elsewhere (Kuhre et al. 2014a,b).
Expression analysis
Rats were anesthetized as described above and tissue was
harvested, thoroughly rinsed in 0.9% NaCl (room tempera-
ture) and transferred to RNA-later and stored at 4°C. Total
RNA was extracted from homogenized rat intestine tissue
(full thickness tissue) using TRIzol (Invitrogen). RNA
(1 lg) was treated with DNase I and reverse-transcribed
using the High-Capacity cDNA RT (reverse transcription)
kit from Applied Biosystems. qPCR was performed using
SYBR Green PCR Mastermix from Applied Biosystems and
a program of: 2 min at 50°C and 10 min at 95°C, followed
by 40 cycles of 15 sec at 95°C and 60 sec at 60°C. Sodium-
glucose cotransporter 1 (SGLT1 aka. solute carrier family 5
member 1 (Slc5a1) mRNA was quantified by use of follow-
ing primers: Forward: CAAGATCCGGAAGGGTGCAT:
backward: TGTAGTCAAAGAGCTGCCCG. rPO (riboso-
mal phosphoprotein) was used as a reference gene, and
qPCR data were analyzed using the 2(ΔΔct) method.
Samples were analyzed in triplicates.
Biochemical measurements
Glucose concentration in perfusion effluent was mea-
sured by a handheld glucometer, based on the glucose-
oxidation method (Accu-chek Compact plus device;
Roche, Mannheim, Germany). Coefficient of variation
was less than 20% in the range 0.1–1 mmol/L. GLP-1
concentration in venous effluent was measured by in-
house RIA (assay code: 89-390) based on a so-called
“terminal-wrapping” antibody recognizing the amidated
c-terminal part of the molecule, thus measuring total
GLP-1 (1–36NH2, 7–36NH2, and 9–36NH2), but not
glycine extended isoforms of GLP-1 x -37(Orskov et al.
1994). The assay has a detection limit of 1 pmol/L with
an intraassay coefficient of variation of 6%.The choice
of targeting amidated isoforms of the molecule was
based on previous studies from our group showing that
the rat intestine predominantly stores amidated GLP-1
(Kuhre et al. 2014a). Similarly, total NT and total PYY
were measured using in-house RIA assays, employing C-
terminally targeting antibodies for both peptides, thus
measuring both intact (NT 1–13 and PYY 1–36) and
cleaved isoforms ((Kuhre et al. 2015); (Torang et al.
2016)). For the NT assay, the detection limit is 2 pmol/
L with an intraassay coefficient of variation of 9% and
the PYY assay had comparable characteristics.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Data presentation and statistics
Data are presented as means  SEM for perfusion data.
Statistical analysis was applied to test if hormone outputs
differed between baseline and during glucose stimulation
and if the secretory output during glucose instillation dif-
fered between the respective intestinal segments. Glucose
absorption was calculated by subtracting the arterial glu-
cose supply (3.5 mmol/L 9 flow, corresponding to a deliv-
ery of 26.25 lmol/min to the USI and LSI and 10.5 lmol/
min to the colon) from the venous glucose outputs.
Response outputs (n = 7–9) were calculated over a period
from start of glucose administration until the end of stimu-
lation (indicated in the graphs), and baseline outputs were
calculated for the same number of minutes as the stimula-
tion period. Correlations between glucose absorption
(lmol) and hormone outputs (fmol) were calculated by
linear regression analysis. Total glucose absorption at base-
line (lmol, 10 min preceding the luminal glucose adminis-
tration) and during luminal glucose administration (lmol,
also a 10 min period) was plotted against total hormone
output in the same periods. 95% confidence intervals are
depicted in the respective graphs. Expression data are
expressed relative to the concentration in the first tissue
sample (1 cm from pylorus). Within group significance
(n = 7–9) was assessed by paired t-test (perfusions) or by
one-way-ANOVA for repeated measurements between
group comparison for the perfusion data and expression
analysis data (n = 3)) followed by Tukey’s post hoc test.
Between group significance (perfusion data, baseline sub-
tracted secretory outputs in response to glucose stimula-
tion, n = 7–9) was evaluated by one-way ANOVA followed
by Tukey’s post hoc test. For all tests, P < 0.05 was consid-
ered significant. Calculations were made using GraphPad
Prism 6 software (La Jolla, CA) and graphs were con-
structed in GraphPad and edited in Adobe Illustrator.
Results
Glucose absorption
Isolated rat intestine perfusions
Intraluminal glucose administration in the USI rapidly
increased glucose absorption (baseline = 3.75  1.1 lmol/
min vs. stimulated = 93.5  18 lmol/min, P < 0.01,
n = 7, Fig. 1A and B). A similar increase in glucose absorp-
tion was observed from the LSI after luminal glucose (base-
line = 3.21  0.6 lmol/min vs. stimulation = 70.0 
6.9 lmol/min, Fig. 1C and D), whereas glucose output
from the colon increased twofold in 6/8 experiments
(Fig. 1E and F) but was on average six to ninefold lower
than the total absorption in the USI and LSI over a 10-min
period (USI = 935  177 lmol, LSI = 735.1  78 lmol,
colon = 107.7  37 lmol, n = 6–7, PUSI vs. LSI = 0.46,
PUSI vs. colon < 0.001, PLSI vs. colon < 0.001, n = 6–8,
Fig. 1G). However, the difference between the USI and LSI
compared to the colon mainly resulted from the difference
in segmental lengths, as the incremental glucose absorption
(during response) per cm was not significantly different:
USI = 20.41  1.62 lmol/cm, LSI = 15.31  1.62 lmol/
cm, colon: 12.01  3.1 lmol/cm (P > 0.05 for all groups,
Fig. 1I).
Tissue expression of sodium-glucose
cotransporter 1 (SGLT1)
SGLT1 expression was mainly restricted to the upper 2/3
of the small intestine with low expression in the terminal
part of the small intestine, the cecum and proximal part
of the colon. In the distal part of the colon, SGLT1 was,
however, expressed at levels comparable to those found
45 cm from pylorus (the site of highest expression in the
small intestine) (Fig. 1I¸ n = 3).
SGLT1- and GLUT2-mediated glucose absorption
Having established that the small intestine is the major
site of glucose absorption, we next investigated the role of
the glucose transporters SGLT1 and GLUT2 for glucose
absorption in this intestinal segment. Luminal glucose
(100 mmol/L) was rapidly absorbed, but the absorption
was reduced by approximately 30% upon SGLT1 and
GLUT2 inhibition with phloridzin and phloretin, respec-
tively (absorption in response to: glucose =
254.2  20.7 lmol, glucose + phloridzin + phloretin =
179.6  32.6 lmol, Fig. 1J and K, n = 5, P = 0.012). The
attenuated glucose absorption was not related to a gener-
ally reduced glucose absorption at the second time of glu-
cose administration as the absorption at the second time
of glucose administration (20% w/v) without inhibitors
was identical to that of the first administration (glucose
absorption: first stimulation = 508.0  101 lmol vs. sec-
ond stimulation = 487.8  110.9, n = 6, P = 0.70, data
not shown).
Glucose-stimulated GLP-1, NT, and PYY
secretion from the upper and lower small
intestine and the colon and the relationship
with glucose absorption
GLP-1
Glucose induced robust and similar GLP-1 responses
from the USI and the LSI, with total secretion increasing
approximately eightfold compared to baseline (GLP-1
2017 | Vol. 5 | Iss. 23 | e13507
Page 4
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society
Glucose Absorption and GLP-1, NT, and PYY Secretion. R. E. Kuhre et al.
output during a similar time span immediately preceding
the stimulation (USI: baseline output = 0.67  0.90 pmol
vs. stimulated output = 4.90  0.65 pmol, LSI: baseline
output 0.66  0.11 pmol vs. response = 4.33  0.60 pmol,
P < 0.001 compared to respective baselines, Fig. 2A–F).
Basal GLP-1 secretion from the colon was approximately
fivefold lower and glucose only elicited a modest, but signifi-
cant, increase in GLP-1 secretion (output base-
line = 0.22  0.03 pmol vs. response = 0.41  0.05 pmol,
P < 0.01, n = 8, Fig. 2G–I). Overall, the glucose-stimulated
GLP-1 response was approximately 10-fold greater from the
USI and LSI compared to the colon but did not differ
significantly between USI and LSI (baseline subtracted out-
puts during glucose infusion: USI = 3.4  0.5 pmol,
LSI = 3.0  0.5 pmol, colon 0.2  0.04 pmol, PUSI vs.
LSI = 0.70, PUSI or LSI vs. colon < 0.001, n = 6–8, Fig. 1J). In
the USI, LSI, and colon, GLP-1 secretion correlated posi-
tively with glucose absorption rate (USI: R2 = 0.59, LSI:
R2 = 0.69, colon: R2 = 0.74, all P < 0.01, Fig. 2C, F, and I).
Adjusted for segmental length, the secretory GLP-1 response
to glucose from the USI was comparable to that from the
LSI, and both were 3–4 times larger than the secretion from
colon (baseline subtracted secretory output during glucose
infusion: USI = 75  11 fmol/cm, LSI = 62  10 fmol/cm,
colon = 20  5 fmol/cm, PUSI vs. LSI = 0.59, PUSI or LSI vs.
colon < 0.01, Fig. 2K). In all cases, the regression line passed
close to 0.0, suggesting that there was little secretion without
glucose absorption.
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NT
Glucose generated similar NT responses from the USI
and LSI, resulting in about fivefold increase in total NT
output during glucose infusion (response) compared to
the basal secretion over a similar time interval immedi-
ately preceding stimulation (USI: 1.0  0.3 pmol vs.
3.0  0.3 pmol, LSI: 0.7  0.1 pmol vs. 3.6  0.8 pmol,
both P < 0.01 compared to respective baselines, incre-
mental outputs: USI = 2.2  0.3 pmol vs.
2.9  0.7 pmol, P = 0.22, n = 7, Fig. 3A, B, D, E, and
G). In contrast, NT was not secreted from the colon in
detectable amounts (lower limit of quantification ~ 1 pM,
data not shown). NT secretion and glucose absorption
correlated positively but to a lower extent than the case
for GLP-1 secretion (USI: R2 = 0.45, P < 0.01, LSI:
R2 = 0.52, P < 0.01, Fig. 3C and F). Probably the differ-
ence is driven by that NT plateaued already at small
increases in glucose absorption (output) (Fig. 3C and F).
Glucose-stimulated NT secretion did not differ between
the USI and LSI when adjusted for segmental length
(baseline-subtracted outputs (fmol/cm):
USI = 47.35  5.61, LSI = 60.50  15.6, P = 0.44,
Fig. 3H).
PYY
Glucose elicited a small but significant secretory PYY
response from the USI (basal secretion = 0.3  0.04 pmol
vs. 0.6  0.06 pmol, P < 0.05, Fig. 4A and B) and from
the colon (basal secretion = 0.1  0.01 pmol vs.
0.2  0.02 pmol, P < 0.001, Fig. 4G and H), but PYY was
predominately secreted from the LSI (Fig. 4D and E),
where glucose administration resulted in a secretory
response that was 10- to 15-fold higher than those from the
USI and colon (outputs (pmol): USI = 1.3  0.03,
LSI = 1.2  0.3, colon = 0.07  0.01, PLSI vs. USI or
colon < 0.001, n = 7–8, Fig. 4J). The association between
PYY secretion and glucose absorption was: USI: R2 = 0.27,
P = 0.05, LSI = R2 = 0.41, P = 0.05, colon: R2 = 0.39,
P < 0.01 in all cases, Fig. 4C, F, and I). Taking the differ-
ence in segmental length into account, the secretory poten-
tial per cm was 3–8 times larger in the LSI than in the USI
and colon, respectively (length adjusted incremental out-
puts (fmol/cm): USI = 2.93  0.6, LSI = 24.3  6.1,
colon = 6.7  1.0, PLSI vs. USI or colon < 0.01 Fig. 4K).
Discussion
Several studies have addressed the molecular mechanisms
underlying the secretion of the appetite- and metabolism-
regulating hormones, GLP-1, NT, and PYY during the last
decade, as recently reviewed (Gribble and Reimann 2016;
Husted et al. 2017), but less attention has been devoted
to analysis of the segments of the gut from where these
hormones are secreted in response to different secre-
tagouges (e.g., amino acids, bile acids, glucose, short- and
long-chain fatty acids, and proteins). Clearly, the expres-
sion levels of different molecular sensors in intestinal
epithelium of mice and humans vary along the intestine
(Symonds et al. 2015) and this may result in different
regional responses of GLP-1, NT, and PYY to different
stimuli. In particular, the colon has only to a limited
extent been studied for its endocrine secretion, albeit tra-
ditional analysis (immunohistochemistry) of human and
rat intestinal sections has demonstrated that the highest
density of the GLP-1 producing L cells is found here
(Larsson et al. 1975; Larsson and Rehfeld 1978; Varndell
et al. 1985; Evers et al. 1993; Theodorakis et al. 2006
Svendsen et al. 2015; Wewer Albrechtsen et al. 2016).
However, conventional analysis does not take into
account the differences in surface area and length of the
different regions of the intestine; if this is done, one may
find in humans that although sparse in density, the total
L-cell numbers are higher in the upper jejunum and
ileum than in the large intestine (Nauck 1998), and
experimental (unbiased) stereology data from rats have
shown that L cells are distributed rather evenly through-
out the jejunum, ileum, and colon (Hansen et al. 2013).
In humans, glucose ingestion elevates plasma NT, GLP-
1, and PYY levels (Jacobsen et al. 2012), and glucose
appears in healthy subjects to be the most effective secret-
agogue for GLP-1 (Jensen et al. 2016). Studies from
several independent groups have suggested that glucose-
stimulated GLP-1 and NT secretion relies on L-/N-cell
mediated uptake of glucose through SGLT1, which gives
rise to depolarization of the N/L cell, opening of voltage-
gated calcium channels and influx of extracellular calcium
(Gribble et al. 2003; Parker et al. 2009; Gorboulev et al.
2012; Mace et al. 2012; Kuhre et al. 2014b, 2015; R€oder
et al. 2014; Gribble 2015) although a contribution from
metabolism of glucose and GLUT2 depending mecha-
nisms may also play a role (Mace et al. 2012; Kuhre et al.
2014b). In addition, little is known about the relative
expression of SGLT1 in GLP-1, NT, and PYY-positive
cells in the upper and lower small intestine and in the
colon, and the ability of the endocrine cells in the differ-
ent parts of the intestine to respond to and/or transport
glucose is also unknown. Our results show that glucose is
absorbed by and stimulated GLP-1 secretion from the
USI and LSI to a comparable extent, whereas both
absorption and secretion from the colon was 10- to 15-
fold lower. The segmental differences in glucose absorp-
tion were driven by differences in segmental lengths, as
the colon absorbed glucose at a rate which was numeri-
cally lower but not significantly different from those of
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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the USI and LSI per cm tissue. The specific focus of this
study was to investigate the relationship between the
absolute glucose absorption capacity and the resulting
secretion of GLP-1, NT, and PYY secretion in the
different intestinal segments. Therefore, a high glucose
concentration was administered (20% w/v ~1.1 mol/L).
Although not investigated in classical concentration–re-
sponse manner, the glucose absorption is likely operating
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at full capacity in our experiments as only 10–20% of the
administered glucose was absorbed in the USI and LSI
(delivery = 550 lmol/min, absorption = 60–130 lmol/
min), whereas in the colon only 6–12% of the infused
glucose was absorbed (delivery = 165 lmol/min, absorp-
tion = 10–20 lmol/min). The expression of SGLT1 did
not fully parallel glucose absorption capacity in the differ-
ent segmental areas, as higher expression was evident in
USI than in LSI, whereas glucose absorption was similar.
While we have not been able to narrow down the reason
for this discrepancy, it could reflect that the relationship
between SGLT1 mRNA and functional protein is complex
and/or that SGLT1 activity is regulated posttranslationally.
In line with the latter, SGLT1 activity in Xenopus laevis
oocytes largely depended on PKC- or PKA-mediated inte-
gration of SGLT1 into the membrane (Hirsch et al. 1996;
Wright et al. 1997). Additionally, expression analysis on
L-cell marker positive and L-cell marker negative cells
(presumably dominated by enterocytes) from the mouse
have shown that GLUT2 expression is substantially lower
in both L-cell positive and L-cell negative cells from the
lower third of the small intestine and colon, compared to
the upper third of the small intestine (about 8- to 128-
fold lower, respectively) (Reimann et al. 2008). As glucose
absorption depends on both transport across the luminal
side (presumably mostly mediated by SGLT1 activity but
possibly also facilitated by GLUT2 translocation from the
basolateral to the apical side of the enterocyte (Kellett
et al. 2008)) and exit across the basolateral membranes of
the enterocytes (through GLUT2), the low glucose
absorption and glucose-stimulated GLP-1 secretion in the
colon may be related to low levels of GLUT2 expression
here compared to the upper small intestine (in both L
cells and enterocytes), with basolateral exit of glucose
being a rate-limiting factor for glucose absorption.
Indeed, glucose absorption was reduced with about 30%
when SGLT1 and GLUT2 were inhibited by luminal
administration of the transporter inhibitors phloridzin
and phloretin (the latter was added to inhibit potentially
translocated GLUT2 transporters). It is noteworthy that
the inhibitors only reduced but did not eliminate absorp-
tion, and the underlying reason for this clearly requires
further investigation. Our observation could, however, be
related to that the glucose concentration in these experi-
ments (100 mmol/L) was relatively high compared to
other studies of this (Helliwell and Kellett 2002; Mace
et al. 2012) albeit not supraphysiological (Ferraris et al.
1990). Supporting this notion, it is generally accepted that
glucose absorption comprises two components; a sec-
ondary active as well as a facilitated component both of
which operate at low glucose concentrations and saturate
at 30–50 mmol/L, and a passive component allowing lin-
ear increases in absorption up to at least 100 mmol/L
(Fullerton and Parsons 1956; Manome and Kuriaki 1961;
Lostao et al. 1991; Kellett et al. 2008). The relative roles
of the secondary active (SGLT1-mediated) and the facili-
tated (GLUT2-mediated) component is a matter of
debate. It is, however, noteworthy that elimination of
SGLT1 activity by either genetic knock out (in mice), by
pharmacological inhibition or by depletion of sodium
ions (which drives SGLT1-transport from the glucose
solution) reduces but does not eliminate glucose absorp-
tion in mice (Gorboulev et al. 2012; R€oder et al. 2014),
isolated perfused rat small intestine loops (Mace et al.
2012) and in humans (Olsen and Ingelfinger 1968). NT
secretion showed a similar pattern with fivefold higher
rates of secretion from the USI and LSI compared to
basal levels. In contrast, NT was undetectable in effluent
from the colon (assay detection limit ~1 pM). PYY was
predominantly secreted from the LSI where glucose
increased the secretion four to fivefold. Glucose also
increased the secretion from the USI and colon, but the
secretory rate was in both cases 10- to 15-fold lower than
that from the LSI (Fig. 4A–G). The regional difference of
in particular glucose-stimulated NT and PYY secretion we
find in this study supports the conclusion of two recent
papers showing, based on expression analysis of isolated
purified murine L cells, that L cells from the upper small
intestine differs markedly compared to L cells from the
distal small intestine and colon (Egerod et al. 2012; Habib
et al. 2012). Indeed, L cells from the upper small intestine
resembled CCK producing I-cells and GIP producing K-
cells more than distal small intestinal L cells, suggesting
that the former may comprise a certain rather promiscu-
ous cell type, whereas L cells from the colon are more dif-
ferentiated and only express GLP-1 and PYY in
appreciable amounts (Habib et al. 2012). Furthermore
immunohistochemical studies on mice, rats, and pigs
have suggested that the degree of colocalization between
GLP-1 and other intestinal hormones (CCK, GIP, NT,
and PYY) differs down the intestine (Cho et al. 2015;
Grunddal et al. 2016; Svendsen and Holst 2016), further
supporting that the traditional definition of an L cell as a
cell type that exclusively expresses GLP-1 (and the other
intestinal proglucagon-derived peptides glicentin, oxynto-
modulin, and GLP-2) needs revision. Our findings suggest
that GLP-1 secretion is indeed tightly coupled to glucose
absorption in the small intestine. As SGLT1 also was
expressed in the high levels in the distal part of the colon,
it is possible that a similar mechanism is operating here,
but probably plays minor role for the total intestinal glu-
cose absorption because (1) the majority of glucose is
absorbed in the small intestine; (2) because of the smaller
length of the colon; and (3) perhaps because of a rela-
tively lower expression of GLUT2. In fact, very little is
known about colonic secretion of GLP-1, which does not
2017 | Vol. 5 | Iss. 23 | e13507
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seem to contribute to the GLP-1 response to meal inges-
tion, as evidenced by studies in people after total colec-
tomy (Nauck et al. 1996). It is often assumed that colonic
GLP-1 secretion is stimulated by volatile fatty acids gener-
ated by fermentation (Psichas et al. 2005; Zhou et al.
2008; Freeland and Wolever 2010; Tolhurst et al. 2012),
but this view is challenged by that germ-free mice (which
lack microbial short-chain fatty-acid production) have
increased rather than decreased basal GLP-1 plasma levels
(Wichmann et al. 2013). Similarly, basal- and meal-
induced secretion of GLP-1 was unaffected in humans
after an aggressive antibiotic treatment that resulted in
near eradication of gut bacteria (Mikkelsen et al. 2015).
Furthermore, in clinical studies there was no relationship
between colonic fermentation and GLP-1 secretion (Rop-
ert et al. 1996). Although the secretory mechanisms for
NT appear to be related to those for GLP-1 (Kuhre et al.
2014b, 2015), the correlation with glucose absorption was
much less tight, which is consistent with the finding that
the majority of NT-positive cells are not GLP-1 positive
(Grunddal et al. 2016). Secretion of PYY from ileal cells
behaves very much like that of GLP-1, consistent with
their colocalization in the ileal L cells, but is clearly very
different in the colon and the USI. On the whole, the
many GLP-1 and PYY secreting cells in the colon are
probably poorly related to those in the LSI, which again
differ remarkably from those of the USI (neither of which
produce or secrete PYY) (Habib et al. 2012). To the
extent that the hormones reach the circulation to act on
distant target receptors, the importance of their regional
origin in relation to the actual response may, however, be
less obvious; but it is likely that all three hormones may,
at least partly, act by activating local receptors which in
turn signals via sensory neurons to, for example, the brain
stem and hypothalamus, and in this case the local expres-
sion of receptors becomes a question of great relevance.
The finding that gastric bypass-operated individuals
both have accelerated glucose absorption and exaggerated
glucose-stimulated GLP-1, NT, and PYY secretion (Jacob-
sen et al. 2013) suggested a link between the two, but this
relationship has not been examined previously in detail
across the different parts of the intestine. Our results are
compatible with the view that under normal circumstances
the bulk of glucose is probably absorbed in the USI,
whereas the LSI probably serves as a reserve capacity for
additional absorption in special cases. Gastric bypass oper-
ations for obesity are associated with markedly exagger-
ated postprandial secretion of several appetite- and
metabolism-regulating hormones (increasing up to 30-fold
(Jørgensen et al. 2012)). The underlying mechanisms of
this remain to be elucidated, but one hypothesis holds that
the diversion of glucose to more distal sites of the intestine
could play a key-role, because the L-cell density is thought
to be greater there (Eissele et al. 1992; Mortensen et al.
2003). As discussed above, this is probably not the case.
However, gastric bypass results in an increased rate of
nutrient delivery to the distal small intestine, and this
undoubtedly explains the increased secretion of PYY. For
GLP-1 the increased secretion is likely to be related to
increased glucose absorption (Jacobsen et al. 2013) as sup-
ported by the present findings. The rapid absorption rate
is likely to be a consequence of the dramatically increased
exposure of the small intestine still continuity to glucose-
containing nutrients due to the lack of gastric retention
after the gastric bypass operation (Falken et al. 2011).
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